RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Peter R. Hoffmann to Inflammatory Bowel Diseases

Back to Details
This is a "connection" page, showing publications Peter R. Hoffmann has written about Inflammatory Bowel Diseases.
Peter R. Hoffmann
Connection Strength
0.739
Inflammatory Bowel Diseases
  1. Schoenefuss F, Hoffmann P. Serum ?-globulin and albumin concentrations predict secondary loss of response to anti-TNFa in inflammatory bowel disease patients. Eur J Gastroenterol Hepatol. 2019 Dec; 31(12):1563-1568.
    View in: PubMed
    Score: 0.636
  2. Huang Z, Rose AH, Hoffmann FW, Hashimoto AS, Bertino P, Denk T, Takano J, Iwata N, Saido TC, Hoffmann PR. Calpastatin prevents NF-?B-mediated hyperactivation of macrophages and attenuates colitis. J Immunol. 2013 Oct 01; 191(7):3778-88.
    View in: PubMed
    Score: 0.103
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support